Exagamglogene autotemcel (exa-cel) gene therapy offers a potential cure for severe sickle cell disease, now available on NHS.

A group of sustainable finance experts tasked with advising the European Union have proposed changes to the bloc's rules for ...

Deregulating New Zealand's gene tech space has been long-desired, but critics say the Government's growth-focused approach goes too far and risks too much, reports Fox Meyer ...

Gene technology has been earmarked for expansion in New Zealand, but without robust regulation local communities could be ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation....more ...

Bengaluru (Karnataka) [India], January 16: Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics laboratory in Bengaluru. The new ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Some promising updates are there." However, Srivastava said there may be another way forward—gene editing, which is different from genetic modification because it does not insert DNA sequences ...

The Grand View Research report also notes that the shift toward more flexibility in European regulations regarding gene editing in agriculture has been a driver for investment in this specific area.